Childhood cancers, sickle cell treatment now covered by NHIS, says Bawumia
Announcing this on Thursday (25 August 2022) in Accra, Bawumia said reimbursement of childhood cancers under NHIS became effective on 1 July 2022. Treatments for childhood cancers, as well as the cost of Hydroxyurea, an essential drug for the treatment of sickle cell anaemia, are now covered by the National Health Insurance Scheme (NHIS).